FDA

The planned resignation of Marty Makary from the US Food and Drug Administration is creating fresh uncertainty over abortion access across the United States, particularly regarding the future of abortion pills prescribed through telehealth and delivered by mail.

Makary, who faced criticism from anti-abortion groups during his tenure as FDA commissioner, is expected to leave the agency amid growing political pressure from conservative activists and internal tensions within the Trump administration.

The development matters because the FDA now sits at the center of one of the country’s most significant legal and political battles over abortion access. [Read more…] about Why one FDA resignation could affect abortion access across America

Missouri’s attorney general has failed, for now, in an attempt to immediately halt the sale of controversial kratom-derived products sold by Kansas City-based CBD American Shaman, in a case that highlights growing national debate over the increasingly popular substance.

Jackson County Circuit Judge Charles McKenzie ruled Friday that the state had not yet presented sufficient evidence to justify an emergency temporary restraining order against the company and several affiliated businesses.

The lawsuit, brought by Missouri Attorney General Catherine Hanaway alongside the Missouri Department of Health and Senior Services, specifically targets products containing “7-OH” – short for 7-hydroxymitragynine – a potent compound derived from kratom. [Read more…] about Missouri judge declines to immediately halt controversial kratom product sales